NYSE:BAX - Baxter International Stock Price, Forecast & News

Baxter International trades on the New York Stock Exchange (NYSE) under the ticker symbol "BAX."

Baxter International declared a quarterly dividend on Tuesday, November 19th. Shareholders of record on Friday, December 6th will be given a dividend of $0.22 per share on Thursday, January 2nd. This represents a $0.88 annualized dividend and a yield of 0.97%. The ex-dividend date of this dividend is Thursday, December 5th. View Baxter International's Dividend History.

Baxter International announced that its board has approved a stock repurchase program on Tuesday, November 13th 2018, which allows the company to buyback $2,000,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization allows the company to reacquire up to 6.1% of its shares through open market purchases. Shares buyback programs are usually a sign that the company's board of directors believes its stock is undervalued.

Baxter International Inc (NYSE:BAX) issued its quarterly earnings results on Wednesday, October, 31st. The medical instruments supplier reported $0.80 EPS for the quarter, beating analysts' consensus estimates of $0.74 by $0.06. The medical instruments supplier earned $2.77 billion during the quarter, compared to analyst estimates of $2.79 billion. Baxter International had a return on equity of 22.99% and a net margin of 13.80%. The company's quarterly revenue was up 2.2% on a year-over-year basis. During the same quarter last year, the company posted $0.64 earnings per share. View Baxter International's Earnings History.

Baxter International is scheduled to release their next quarterly earnings announcement on Thursday, January 30th 2020. View Earnings Estimates for Baxter International.

15 Wall Street analysts have issued twelve-month price objectives for Baxter International's stock. Their forecasts range from $75.00 to $109.00. On average, they anticipate Baxter International's stock price to reach $93.15 in the next year. This suggests a possible upside of 2.2% from the stock's current price. View Analyst Price Targets for Baxter International.

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Baxter International in the last year. There are currently 4 hold ratings and 11 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Baxter International.

News articles about BAX stock have trended somewhat negative on Thursday, InfoTrie reports. The research group rates the sentiment of press coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Baxter International earned a media sentiment score of -1.0 on InfoTrie's scale. They also assigned media coverage about the medical instruments supplier a news buzz of 3.0 out of 10, indicating that recent press coverage is unlikely to have an effect on the stock's share price in the next few days. View News Stories for Baxter International.

Baxter International saw a decline in short interest in the month of December. As of December 13th, there was short interest totalling 4,300,000 shares, a decline of 18.4% from the November 28th total of 5,270,000 shares. Based on an average daily volume of 2,860,000 shares, the short-interest ratio is presently 1.5 days. Approximately 0.8% of the company's stock are sold short. View Baxter International's Current Options Chain.

Some companies that are related to Baxter International include Medtronic (MDT), Abbott Laboratories (ABT), Stryker (SYK), Becton Dickinson and (BDX), Intuitive Surgical (ISRG), Boston Scientific (BSX), Edwards Lifesciences (EW), IDEXX Laboratories (IDXX), ResMed (RMD), DexCom (DXCM), Teleflex (TFX), Hologic (HOLX), Varian Medical Systems (VAR), Steris (STE) and Insulet (PODD).

Based on aggregate information from My MarketBeat watchlists, some companies that other Baxter International investors own include CA (CA), Cisco Systems (CSCO), BlackRock (BLK), Johnson & Johnson (JNJ), Verizon Communications (VZ), Honeywell International (HON), Alibaba Group (BABA), Home Depot (HD), Procter & Gamble (PG) and AT&T (T).

Baxter International's stock is owned by a variety of of retail and institutional investors. Top institutional investors include SPF Beheer BV (0.20%), Calamos Advisors LLC (0.19%), Marathon Asset Management LLP (0.17%), Huntington National Bank (0.10%), PGGM Investments (0.09%) and Gateway Investment Advisers LLC (0.06%). Company insiders that own Baxter International stock include Andrew Frye, Brik V Eyre, Carole J Shapazian, Giuseppe Accogli, Jacqueline Kunzler, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Scott Pleau, Third Point Llc and Thomas T Stallkamp. View Institutional Ownership Trends for Baxter International.

BAX stock was sold by a variety of institutional investors in the last quarter, including Zurcher Kantonalbank Zurich Cantonalbank, Meag Munich Ergo Kapitalanlagegesellschaft MBH, Bangor Savings Bank, United Services Automobile Association, Janney Montgomery Scott LLC, Gateway Investment Advisers LLC, CENTRAL TRUST Co and Calamos Advisors LLC. Company insiders that have sold Baxter International company stock in the last year include Andrew Frye, Giuseppe Accogli, Jacqueline Kunzler, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Scott Pleau, Third Point Llc and Thomas T Stallkamp. View Insider Buying and Selling for Baxter International.

BAX stock was acquired by a variety of institutional investors in the last quarter, including PGGM Investments, Marathon Asset Management LLP, Benson Investment Management Company Inc., SPF Beheer BV, Nisa Investment Advisors LLC, FormulaFolio Investments LLC, Huntington National Bank and DNB Asset Management AS. View Insider Buying and Selling for Baxter International.

Shares of BAX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of BAX stock can currently be purchased for approximately $91.16.

Baxter International has a market capitalization of $46.54 billion and generates $11.13 billion in revenue each year. The medical instruments supplier earns $1.62 billion in net income (profit) each year or $3.05 on an earnings per share basis. Baxter International employs 50,000 workers across the globe.View Additional Information About Baxter International.

The official website for Baxter International is http://www.baxter.com/.

Baxter International's mailing address is One Baxter Parkway DF2-1W, DEERFIELD IL, 60015. The medical instruments supplier can be reached via phone at 224-948-2000 or via email at [email protected]